Gossamer Bio (GOSS.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov24

Gossamer Bio Inc. to Attend Piper Sandler Annual Healthcare Conference

21:01

Nov6

Gossamer Bio released FY2025 9 Months Earnings on November 5, 2025 (EST) with actual revenue of USD 34.67 M and EPS of USD -0.543

04:00

Gossamer Bio released FY2025 Q3 earnings on November 5 (EST), actual revenue USD 13.29 M (forecast USD 6.381 M), actual EPS USD -0.2115 (forecast USD -0.1871)

04:00

Nov5

Gossamer Bio Inc. updates seralutinib development for pulmonary hypertension

21:37

Sep22

Gossamer Bio to Present Scientific Reports on Seralutinib at ERS Congress

11:31

Aug6

Gossamer Bio released FY2025 Q2 earnings on August 5 (EST), actual revenue USD 11.49 M (forecast USD 5.409 M), actual EPS USD -0.1699 (forecast USD -0.1749)

03:00